The post Gains 3% as SBI Lending and ETF Catalyst Drive Flows appeared on BitcoinEthereumNews.com. XRP extended gains above $3.00 as institutional desks pressed bids into elevated volumes, confirming a short-term floor near $2.99. Japan’s SBI lending rollout and a pending U.S. ETF decision cycle framed the move, with resistance capping at $3.10 after heavy prints. News Background XRP climbed 3% between Oct. 2, 04:00 and Oct. 3, 03:00, rising from $2.98 to $3.03. The rally followed SBI Holdings’ expansion of institutional XRP lending services, signaling Japan’s deepening crypto push. Meanwhile, Ripple CTO David Schwartz announced his departure after 13 years, and seven XRP ETF applications remain under SEC review, with the first decisions expected Oct. 18. Prediction markets now price approval odds above 99%, reinforcing speculative inflows. Price Action Summary XRP traded a $0.15 corridor (4.9% range) between $2.95 and $3.10. At 16:00, price spiked from $3.00 to $3.06 on 212.6M tokens — more than double the daily average. Resistance hardened at $3.10, where 129M in turnover capped upside. XRP consolidated between $3.00–$3.05, signaling accumulation above the $3.00 line. In the final hour, XRP dipped from $3.03 to $3.02 amid profit-taking, with a 2.35M spike at 03:55 showing institutional rebalancing. Technical Analysis Support is confirmed near $2.99–$3.00, with multiple defenses holding the level. Resistance remains defined at $3.10, where institutional sellers concentrated. The session carved a consolidation band above $3.00, suggesting professional accumulation. Volume-led breakout attempts validate institutional participation, though conviction remains tethered to a sustained close above $3.10 to unlock the next leg toward $3.20. What Traders Are Watching? Whether XRP can sustain closes above $3.00 and retest $3.10. Institutional positioning shifts ahead of Oct. 18 ETF deadlines. SBI’s lending flows and their impact on Asian liquidity trends. Broader CD20 index confirmation, as alt rotations track XRP’s strength. Source: https://www.coindesk.com/markets/2025/10/03/xrp-gains-3-as-sbi-lending-and-etf-catalyst-drive-flowsThe post Gains 3% as SBI Lending and ETF Catalyst Drive Flows appeared on BitcoinEthereumNews.com. XRP extended gains above $3.00 as institutional desks pressed bids into elevated volumes, confirming a short-term floor near $2.99. Japan’s SBI lending rollout and a pending U.S. ETF decision cycle framed the move, with resistance capping at $3.10 after heavy prints. News Background XRP climbed 3% between Oct. 2, 04:00 and Oct. 3, 03:00, rising from $2.98 to $3.03. The rally followed SBI Holdings’ expansion of institutional XRP lending services, signaling Japan’s deepening crypto push. Meanwhile, Ripple CTO David Schwartz announced his departure after 13 years, and seven XRP ETF applications remain under SEC review, with the first decisions expected Oct. 18. Prediction markets now price approval odds above 99%, reinforcing speculative inflows. Price Action Summary XRP traded a $0.15 corridor (4.9% range) between $2.95 and $3.10. At 16:00, price spiked from $3.00 to $3.06 on 212.6M tokens — more than double the daily average. Resistance hardened at $3.10, where 129M in turnover capped upside. XRP consolidated between $3.00–$3.05, signaling accumulation above the $3.00 line. In the final hour, XRP dipped from $3.03 to $3.02 amid profit-taking, with a 2.35M spike at 03:55 showing institutional rebalancing. Technical Analysis Support is confirmed near $2.99–$3.00, with multiple defenses holding the level. Resistance remains defined at $3.10, where institutional sellers concentrated. The session carved a consolidation band above $3.00, suggesting professional accumulation. Volume-led breakout attempts validate institutional participation, though conviction remains tethered to a sustained close above $3.10 to unlock the next leg toward $3.20. What Traders Are Watching? Whether XRP can sustain closes above $3.00 and retest $3.10. Institutional positioning shifts ahead of Oct. 18 ETF deadlines. SBI’s lending flows and their impact on Asian liquidity trends. Broader CD20 index confirmation, as alt rotations track XRP’s strength. Source: https://www.coindesk.com/markets/2025/10/03/xrp-gains-3-as-sbi-lending-and-etf-catalyst-drive-flows

Gains 3% as SBI Lending and ETF Catalyst Drive Flows

XRP extended gains above $3.00 as institutional desks pressed bids into elevated volumes, confirming a short-term floor near $2.99. Japan’s SBI lending rollout and a pending U.S. ETF decision cycle framed the move, with resistance capping at $3.10 after heavy prints.

News Background

XRP climbed 3% between Oct. 2, 04:00 and Oct. 3, 03:00, rising from $2.98 to $3.03. The rally followed SBI Holdings’ expansion of institutional XRP lending services, signaling Japan’s deepening crypto push. Meanwhile, Ripple CTO David Schwartz announced his departure after 13 years, and seven XRP ETF applications remain under SEC review, with the first decisions expected Oct. 18. Prediction markets now price approval odds above 99%, reinforcing speculative inflows.

Price Action Summary

  • XRP traded a $0.15 corridor (4.9% range) between $2.95 and $3.10.
  • At 16:00, price spiked from $3.00 to $3.06 on 212.6M tokens — more than double the daily average.
  • Resistance hardened at $3.10, where 129M in turnover capped upside.
  • XRP consolidated between $3.00–$3.05, signaling accumulation above the $3.00 line.
  • In the final hour, XRP dipped from $3.03 to $3.02 amid profit-taking, with a 2.35M spike at 03:55 showing institutional rebalancing.

Technical Analysis

Support is confirmed near $2.99–$3.00, with multiple defenses holding the level. Resistance remains defined at $3.10, where institutional sellers concentrated. The session carved a consolidation band above $3.00, suggesting professional accumulation. Volume-led breakout attempts validate institutional participation, though conviction remains tethered to a sustained close above $3.10 to unlock the next leg toward $3.20.

What Traders Are Watching?

  • Whether XRP can sustain closes above $3.00 and retest $3.10.
  • Institutional positioning shifts ahead of Oct. 18 ETF deadlines.
  • SBI’s lending flows and their impact on Asian liquidity trends.
  • Broader CD20 index confirmation, as alt rotations track XRP’s strength.

Source: https://www.coindesk.com/markets/2025/10/03/xrp-gains-3-as-sbi-lending-and-etf-catalyst-drive-flows

Market Opportunity
GAINS Logo
GAINS Price(GAINS)
$0.00764
$0.00764$0.00764
-0.39%
USD
GAINS (GAINS) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26